» Articles » PMID: 34680905

Machine Learning: An Overview and Applications in Pharmacogenetics

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2021 Oct 23
PMID 34680905
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

This narrative review aims to provide an overview of the main Machine Learning (ML) techniques and their applications in pharmacogenetics (such as antidepressant, anti-cancer and warfarin drugs) over the past 10 years. ML deals with the study, the design and the development of algorithms that give computers capability to learn without being explicitly programmed. ML is a sub-field of artificial intelligence, and to date, it has demonstrated satisfactory performance on a wide range of tasks in biomedicine. According to the final goal, ML can be defined as Supervised (SML) or as Unsupervised (UML). SML techniques are applied when prediction is the focus of the research. On the other hand, UML techniques are used when the outcome is not known, and the goal of the research is unveiling the underlying structure of the data. The increasing use of sophisticated ML algorithms will likely be instrumental in improving knowledge in pharmacogenetics.

Citing Articles

Artificial intelligence, medications, pharmacogenomics, and ethics.

Haga S Pharmacogenomics. 2024; 25(14-15):611-622.

PMID: 39545629 PMC: 11703462. DOI: 10.1080/14622416.2024.2428587.


The Role of Vitamin D Metabolism Genes and Their Genomic Background in Shaping Cyclosporine A Dosage Parameters after Kidney Transplantation.

Kotowska K, Wojciuk B, Sienko J, Bogacz A, Stukan I, Drozdzal S J Clin Med. 2024; 13(16).

PMID: 39201108 PMC: 11355102. DOI: 10.3390/jcm13164966.


The impact and future of artificial intelligence in medical genetics and molecular medicine: an ongoing revolution.

Ozcelik F, Dundar M, Yildirim A, Henehan G, Vicente O, Sanchez-Alcazar J Funct Integr Genomics. 2024; 24(4):138.

PMID: 39147901 DOI: 10.1007/s10142-024-01417-9.


The polygenic implication of clopidogrel responsiveness: Insights from platelet reactivity analysis and next-generation sequencing.

Echeverria O, Angulo-Aguado M, Vela R, Calderon-Ospina C, Parra K, Contreras N PLoS One. 2024; 19(7):e0306445.

PMID: 38991024 PMC: 11239111. DOI: 10.1371/journal.pone.0306445.


Pharmacogenomics: Challenges and Future.

Arbitrio M Genes (Basel). 2024; 15(6).

PMID: 38927650 PMC: 11202540. DOI: 10.3390/genes15060714.


References
1.
Cramer D, Mazur J, Espinosa O, Schlesner M, Hubschmann D, Eils R . Genetic Interactions and Tissue Specificity Modulate the Association of Mutations with Drug Response. Mol Cancer Ther. 2019; 19(3):927-936. DOI: 10.1158/1535-7163.MCT-19-0045. View

2.
Maciukiewicz M, Marshe V, Hauschild A, Foster J, Rotzinger S, Kennedy J . GWAS-based machine learning approach to predict duloxetine response in major depressive disorder. J Psychiatr Res. 2018; 99:62-68. DOI: 10.1016/j.jpsychires.2017.12.009. View

3.
Sekhar M, Adheena Mary C, Anju P, Hamsa N . Study on drug related hospital admissions in a tertiary care hospital in South India. Saudi Pharm J. 2013; 19(4):273-8. PMC: 3745191. DOI: 10.1016/j.jsps.2011.04.004. View

4.
Truda G, Marais P . Evaluating warfarin dosing models on multiple datasets with a novel software framework and evolutionary optimisation. J Biomed Inform. 2020; 113:103634. DOI: 10.1016/j.jbi.2020.103634. View

5.
Su R, Liu X, Wei L, Zou Q . Deep-Resp-Forest: A deep forest model to predict anti-cancer drug response. Methods. 2019; 166:91-102. DOI: 10.1016/j.ymeth.2019.02.009. View